Neurol. praxi. 2008;9(1):53

Postihnutie mozočka pri dedičných poruchách glykozylácie

MUDr. Vladimír Bzdúch, CSc.
I. detská klinika LF UK a DFNsP, Bratislava

So záujmom som si prečítal súbor článkov o ochorení mozočka v časopise Neurológia pre prax 5/2007 (13, 15, 16). Ako v úvode napísal doc. MUDr. M. Bareš, Ph.D., cieľom tejto témy bolo zrozumiteľným spôsobom predstaviť klinické jednotky, pri ktorých dochádza k postihnutiu mozočka (2). Vo svojom príspevku by som chcel prispieť k tejto problematike stručnou charakteristikou pomerne novej, ale stále sa rozširujúcej skupiny dedičných porúch glykozylácie (CDG syndróm), pri ktorej je postihnutie mozočka pomerne častým nálezom.

Published: March 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bzdúch V. Postihnutie mozočka pri dedičných poruchách glykozylácie. Neurol. praxi. 2008;9(1):53.
Download citation

References

  1. Antoun H, Villeneuve N, Panisset S et al. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1. Pediatr Radiol 1999; 29: 194-198. Go to original source... Go to PubMed...
  2. Bareš M. Onemocnění mozečku. Neurol. pro praxi 2007; 8(5): 267.
  3. Barone R, Pavone L, Fiumara A et al. Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency). Brain Dev. 1999; 21: 260-263. Go to original source... Go to PubMed...
  4. D´Arrigo S, Vigano L, Bruzzone MG et al. Diagnostic Approach to Cerebellar Disease in Children. J Child Neurol 2005 20: 859-866. Go to original source... Go to PubMed...
  5. Di Rocco M, Barone R, Adami A et al. Carbohydrate - deficient glycoprotein syndromes: the Italian experience. J Inherit Metab Dis. 2000; 23: 391-395. Go to original source... Go to PubMed...
  6. Drouin-Garraud V, Belgrand M, Grunewald S et al. Neurological Presentation of a Congenital Disorder of Glycosylation CDG-Ia: Implication for Diagnosis and Genetic Counseling. Amer J Med Genet 2001; 101: 46-49. Go to original source... Go to PubMed...
  7. Honzík T, Hansíková H, Flachsová E et al. Klinické projevy a výsledky metabolických a molekulárních analýz u osmi dětí s dědičnou poruchou glykosylace proteinu. Čes.-slov. Pediatr. 2003; 58: 456-460.
  8. Honzík T, Maloňová E, Hansíková H et al. Dědičné poruchy glykosylace proteinu typ Ia: klinická, biochemická a molekulární charakteristika u dvou sourozencu s hypoplázii mozečku. Čas. Lék. čes. 2003; 142: 276-279.
  9. Jaeken J, Hagberg B, Stromme P. Clinical Presentation and Natural Course of the Carbohydrate-deficient Glycoprotein Syndrome. Acta Paediatr Scand Suppl 1991; 375: 6-13. Go to original source...
  10. Jaeken J, Vander Vanderschueren-Lodeweyckx M, Casaer P et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr. Res. 1980; 14: 179. Go to original source...
  11. Marklová E, Albahri Z. Průvodce diagnostikou kongenitálních poruch glykosylace (CDG). Čes.-slov. Pediatr. 2003; 58: 426-429.
  12. Morava E, Cser B, Kárteszi J et al. Screening for CDG Ia in Joubert syndrome. Med Sci Monit 2004; 10(8): CR469-CR472.
  13. Sýkora P. Ochorenia mozočka v detskom veku. Neurol. pro praxi 2007; 8(5): 277-282.
  14. Vermeer S, Kremer HPH, Leiten QH et al. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDGIa) with normal routine CDG screening. J Neurol 2007; 254: 1356-1358. Go to original source... Go to PubMed...
  15. Zumrová A, Kopečková M, Mušová Z, Křepelová A, Apltová L, Paděrová K. Autosomálně dominantní spinocerebelární ataxie. Neurol. pro praxi 2007; 8(5): 277-282.
  16. Zumrová A, Mušová Z, Košťálová E, Apltová L, Křepelová A, Paděrová K. Autosomálně recesivní a X-vázané ataxie. Neurol. pro praxi 2007; 8(5): 272-276.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.